MITOXANTRONE INJECTION
Google image searchProduct monograph
Active ingredient
mitoxantrone (mitoxantrone hydrochloride), 2 MG/ML
DIN: 02286300
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 30-DEC-2015
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01D — CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES (ATC, ATC/DDD)
- L01DB — Anthracyclines and related substances (ATC, ATC/DDD)
- L01DB07 — MITOXANTRONE (ATC/DDD)
Reference brand drug: Novantrone
Pharmaceutical standard: USP
